Troubles Persist For Medtronic’s HeartWare Device As FDA Announces Another Class I Recall

 
• By Shawn M. Schmitt
  
Sign of Medtronic at Canada Headquarters in Brampton, Ontario, Canada.

More from Recalls

More from Policy & Regulation